Tomasz Szymanski is pursuing a PhD in the Department of Medicine at Imperial College London. His research focuses on medicines optimization, looking at health economic analysis of medicines review.
Tomasz worked as a consultant at the World Health Organization (WHO) in Copenhagen, Denmark. His work has focused on evaluation of the noncommunicable diseases (NCD) related tools. He has conducted a study that harvested bibliographic details, abstracted the tools, and developed a questionnaire which he has used as the basis for a series of global key informant interviews. Prior to this, he worked on a project with UN Global Pulse and Microsoft on searching of Big Data from social media to retrieve possible new evidence for policy making in the area of NCDs.
He has extensive experience in medicines evaluations gained during his work as a leader of three person team at the Government Agency for Health Technology Assessment (HTA) in Poland. He coordinated more than 25 HTA projects, in which he conducted clinical and cost-effectiveness analysis of medicines. Tomasz gained experience in knowledge translation and evidence informed policy-making by presenting the results of the analyses to the decision makers (Ministry of Health, National Health Fund etc.)